Ban on Misleading Claims: Article 7 of the Tıbbi Cihaz Yönetmeliği, Intended Purpose, Label, Instructions for Use and ÜTS Product Registration

SUMMARY
The ban on misleading claims is regulated in Article 7 of the Tıbbi Cihaz Yönetmeliği (Medical Device Regulation). In four subparagraphs, the Article prohibits statements that could mislead about the intended purpose, safety and performance of a device in labelling, instructions for use, making available on the market, putting into service, and advertising and promotion.
In this post we give, as verbatim quotations, the full text of Article 7, the related definitions, the label and instructions for use provisions in Annex I, Section 23, the equivalent in the In Vitro Diagnostic Regulation, and the guide provisions on labels and images in ÜTS product registration.
For an ÜTS product registration with consistent labels and documents: Medical Device ÜTS Registration Consultancy
Contents
1. What Does Article 7 Prohibit?
Article 7, first paragraph of the Tıbbi Cihaz Yönetmeliği:
“(1) In the labelling, instructions for use, making available on the market, putting into service and advertising/promotion of devices, it is prohibited to use text, names, trade marks, pictures and figurative or other signs that may mislead the user or the patient with regard to the intended purpose, safety and performance of the device by:”
The paragraph lists five fields together: labelling, instructions for use, making available on the market, putting into service, and advertising/promotion. The subject of the ban is text, names, trade marks, pictures and figurative or other signs. What may not be misled about is the intended purpose, safety and performance.
2. The Four Prohibited Subparagraphs
“(a) ascribing to the device functions and properties which the device does not have;”
“(b) creating a false impression regarding treatment or diagnosis, functions or properties which the device does not have;”
“(c) failing to inform the user or the patient of a likely risk associated with the use of the device in line with its intended purpose;”
“(ç) suggesting uses for the device other than those stated to form part of the intended purpose for which the conformity assessment was carried out.”
Subparagraph (a) prohibits ascribing to the device functions and properties it does not have.
Subparagraph (b) prohibits creating a false impression about treatment, diagnosis, functions or properties.
Subparagraph (c) prohibits failing to inform, or only partially informing, about a likely risk associated with use in line with the intended purpose.
Subparagraph (ç) prohibits recommending a use outside the intended purpose for which the conformity assessment was carried out.
3. Definitions: Intended Purpose, Label and Instructions for Use
Two of the four subparagraphs of the Article are tied directly to the intended purpose. Definitions in Article 3:
“(hh) Intended purpose: the use for which a device is intended according to the data supplied by the manufacturer on the label, in the instructions for use or in promotional or sales materials or statements, and as specified by the manufacturer in the clinical evaluation,”
“(n) Label: the written, printed or graphic information appearing either on the device itself, or on the packaging of each unit or on the packaging of multiple devices,”
“(ıı) Instructions for use: the information provided by the manufacturer to inform the user of the device’s intended purpose, proper use and any precautions to be taken,”
“(pp) Performance: the ability of a device to achieve its intended purpose as claimed by the manufacturer,”
The definition of intended purpose covers the label, the instructions for use, promotional/sales materials and the clinical evaluation together. For details, see our page on what intended purpose is.
4. Annex I, Section 23: What the Label and Instructions for Use Must Contain
Annex I, Section 23.1, subparagraph (f), is directly related to the risk notification in subparagraph (c):
“(f) residual risks which are required to be communicated to the user and/or other person shall be included as limitations, contra-indications, precautions or warnings in the information supplied by the manufacturer.”
Some of the details the label carries, under Section 23.2:
“(a) the name or trade name of the device;”
“(b) the details strictly necessary for a user to identify the device, the contents of the packaging and, where it is not obvious to the user, the intended purpose of the device;”
“(j) any warnings or precautions to be taken that need to be brought to the immediate attention of the user of the device and to any other person. This information may be kept to a minimum, in which case more detailed information shall appear in the instructions for use, taking into account the intended users;”
Some of the information the instructions for use contain, under Section 23.4:
“(b) the device’s intended purpose with a clear specification of indications, contra-indications, the patient target group or groups, as well as the intended users, as appropriate;”
“(d) the performance characteristics of the device;”
“(f) any residual risks, contra-indications and any undesirable side-effects, including information to be conveyed to the patient in this regard;”
For the full content of the label and instructions for use and the Turkish language provisions, see our post on Turkish label and instructions for use.
5. IVD Devices: Article 8 of the In Vitro Diagnostic Regulation
The same prohibition is in Article 8 of the İn Vitro Tanı Amaçlı Tıbbi Cihaz Yönetmeliği (In Vitro Diagnostic Medical Device Regulation). The paragraph and subparagraphs (a), (c) and (ç) are the same; subparagraph (b) reads:
“(b) creating a false impression regarding treatment or diagnosis, or functions or properties, which the device does not have.”
6. Misleading Claims in Advertising and Promotion
Article 7 also covers advertising/promotion. The sixth paragraph of Article 18 of the Tıbbi Cihaz Satış, Reklam ve Tanıtım Yönetmeliği (Medical Device Sales, Advertising and Promotion Regulation) separately lists the cases of misleading promotion; the first of them:
“(a) where features the device does not have are presented as if it had them, or any kind of false information is given about the device.”
For the other rules on advertising and promotion, see our post on medical device advertising and promotion rules.
7. Label and Images in ÜTS Product Registration
In Article 27 of the TİTCK ÜTS Registration Guide (TCKKD-KLVZ-03), for the “Orijinal Etiket ve Satış Ambalajı” (Original Label and Sales Packaging) field in the registration of a device under the MDR, it states:
“(4) The information required for the safe use of the device must be on the medical device and/or on the packaging of each part of it or, where necessary, on the commercial packaging (inner/outer packaging).”
For the “Türkçe Etiket” (Turkish Label) field:
“The information entered in ÜTS must be consistent with the information in the label uploaded to the “Orijinal Etiket ve Satış Ambalajı” field referred to in subparagraph (b) of this paragraph and, if any, in the contents of the inner/outer packaging.”
For the “Ürün Görselleri” (Product Images) field:
“(4) The catalogue itself, or an image containing more than one device that makes the device hard to understand, is not uploaded as a product image.”
“If unclear and illegible images are uploaded, the application ends with a negative result.”
For the image and label rules, see our post on ÜTS product image and label rules; for the registration steps, our post on ÜTS medical device product registration.
8. Provisions Applied in Case of Violation
Article 106 of the Tıbbi Cihaz Yönetmeliği:
“(1) For violations of the provisions of this Regulation, the Product Safety and Technical Regulations Law (Ürün Güvenliği ve Teknik Düzenlemeler Kanunu), Turkish Penal Code No. 5237 dated 26/9/2004 and other relevant legislation apply.”
9. Frequently Asked Questions
Does Article 7 cover only advertising?
No. The first paragraph lists labelling, instructions for use, making available on the market, putting into service and advertising/promotion together.
Can a trade mark also count as a misleading claim?
The paragraph lists text, names, trade marks, pictures and figurative or other signs as the subject of the ban. A trade mark that may mislead about the intended purpose, safety and performance is also within the ban.
Is it also prohibited to state a risk incompletely?
Yes. Subparagraph (c) prohibits both failing to inform of, and only partially informing of, a likely risk associated with use in line with the intended purpose.
Can the device be recommended for another use?
Under subparagraph (ç), no use may be suggested for the device other than the intended purpose for which the conformity assessment was carried out.
Can the information entered in ÜTS differ from the label?
Under the TCKKD-KLVZ-03 guide, the label and packaging information uploaded to the “Orijinal Etiket ve Satış Ambalajı” field and the information entered in ÜTS must be consistent with each other.
For an ÜTS product registration with consistent labels and documents: Medical Device ÜTS Registration Consultancy
Sources



